Recent experiments have begun to decipher the functional consequences of the GNAS p.R201C mutation in pancreatic ductal adenocarcinomas, where it modulates KRAS p.G12V initiated neoplasia [48, 49]. This evidence concerns the gene GNAS and pancreatic ductal adenocarcinoma.